, the tDepartment-of Haematology, Llandough Hospital, Cardif, and the tBlood Transfusion Centre, Rhydlafar, Cardif, Wales SUMMARY Peripheral blood and bone marrow were studied in 21 men with disseminated untreated bronchial cancer in an attempt to define abnormalities of erythropoiesis associated with the development of anaemia. Haemoglobin concentration at or below 13 g/dl was present in 13 cases. Marrow morphology was normal in all cases except one, in which small numbers of tumour cells were found. Clonal assay of erythroid progenitors showed a significant decrease in the number of BFU-E (p = 003) and CFU-E (p = 001) compared with cultures from normal marrow (12 subjects). The growth of granulocyte and macrophage progenitors (GM-CFCs) was similar in patients with bronchial cancer and normal subjects. When normal marrow was incubated in the presence of serum from bronchial cancer patients, no inhibitory factors could be detected either for BFU-E or CFU-E growth.
There is, as yet, no satisfactory explanation for anaemia in chronic disease. Ineffective erythropoiesis does not seem to be responsible for the mild anaemias seen in Hodgkin's disease,' myelomatosis,2 and rheumatoid arthritis,3 and this distinguishes the condition from iron deficiency anaemia. Red cell life span is not Severely shortened, but the erythropoietic response to the onset of anaemia seems to be blunted.3 Some workers have attributed this to a failure of erythropoietin production,46 although this remains controversial.7`Circulating inactivators of erythroprotein have been implicated in the anaemia of chronic renal failure."°This could explain why sera from patients with bronchial cancer and rheumatoid arthritis were reported to inhibit in vitro erythropoiesis,11 12 although it seems increasingly likely that failure of erythroid cell production, in vivo and in vitro, is caused by abnormalities in other cell populations which regulate erythroid progenitor cells. Thus monocytes support the in vitro proliferation and differentiation of erythroid colony forming cells in the presence of sera from non-anaemic, but not from Accepted for publication 30 June 1986 anaemic, donors with rheumatoid arthritis."2 Macrophages from anaemic patients with fungal infection inhibit the proliferation of erythroid colony forming cells, whereas they stimulate their development after the infection has been eliminated,"3 and inhibitors of erythropoiesis present in chronic renal failure sera act indirectly by preventing T cells, monocytes, and macrophages from elaborating factors which support in vitro growth of erythroid colony forming cells. 4 Furthermore, quantitative and qualitative changes in T cell subsets have been noted in the anaemia of acquired immune deficiency syndrome (AIDS),'5 16 myelodysplastic syndromes,'7 and aplastic anaemia,'8 and, in the latter two conditions, are associated with moderate to severe depression of numbers of erythroid colony forming cells in the marrow.
We investigated the associations between progenitor cell numbers and serum inhibitory factors, neutrophils, monocytes and T cell subsets in the anaemia of lung cancer.
Material and methods
Marrow aspirates and blood samples were taken from 87 Masters, Baines, Bailey-Wood, Gorvett, Littlewood, Bentley, Parry-Jones, Jacobs 21 newly diagnosed male patients with disseminated bronchial cancer (age range 51-78 years). These comprised 17 In the Ficoll interface fraction prepared from marrow of patients with bronchial cancer per cent T4 values were unchanged and per cent T8 cells showed a significant increase (at the 5% level of probability), which would explain the significantly depressed T4:T8 ratio ( Masters, Baines, Bailey-Wood, Gorvett, Littlewood, Bentley, Parry-Jones, Jacobs I In any case there was no correlation between blood neutrophils and serum iron concentration (r = -0-461; 0 05 < p < 0 1) in our patients.
Monocytes were also increased in the blood of patients with bronchial cancer, but, as for neutrophils, their numbers were not related to the degree of anaemia, and monocyte numbers in the marrows of these patients were similar to normal. The changes in lymphocyte subsets in our patients also deserve comment. The decreased T4:T8 ratio is largely the result of increases in T8 cells in both blood and marrow. In marrow the T4:T8 ratio showed a negative correlation with the number of blood neutrophils (r = -0 525; p < 0 05), but there was no obvious explanation for this.
A reduced T4:T8 ratio has been reported in anaemias associated with AIDS"5 16 and myelodysplasia,"7 and an increased marrow T8 lymphocyte burden has been reported to be responsible for the suppression of erythropoiesis in aplastic anaemia.'8 Lymphocyte function has been shown to be changed both in bronchial cancer2728 and rheumatoid arthritis,29 although blood T lymphocytes from patients with rheumatoid arthritis stimu- lated in vitro erythropoiesis to the same degree as did T lymphocytes from normal donors.12 30 In our patients there were no correlations between lymphocyte subset numbers and haemoglobin concentration, so the importance of the changes in these populations to the aetiology of anaemia in bronchial cancer remains unclear.
The perturbations in neutrophil, monocyte, and lymphocyte populations did not correlate with the reduction in erythroid progenitors in bronchial cancer marrows. It seemed plausible that the increased demand for mature neutrophils in patients with bronchial cancer might be met by increasing GM-CFCs at the expense of erythroid colony forming cell production.25 GM-CFC numbers, however, were not raised in our patients, and the excess blood neutrophils are presumably released from storage pools. The presence of normal numbers of GM-CFCs suggests that the multipotential stem cell compartment is unaffected. Erythropoietic impairment must, then, occur either shortly before the formation of erythroid colony forming cells or soon enough afterwards to prevent the appearance of colonies in vitro and increased erythroblast numbers in vivo.
It is tempting to conclude that impaired growth of erythroid colony forming cells underlies the anaemia in bronchial cancer. Erythroid colony forming cell suppression, however, was most noticeable in the non-anaemic group of patients; anaemic patients showed only an insignificant trend towards fewer erythroid colony forming cells. Furthermore, four of 13 anaemic patients possessed large numbers of CFU-E, and there was no correlation between erythroid colony forming cells and haemoglobin concentrations in patients with bronchial cancer. Consequently, it seems unlikely that the anaemia in all such patients could arise from poor erythroid colony forming cell growth. Tumour cell infiltration into the marrow was noted in only one patient and does not seem to have been responsible for reduced numbers of erythroid colony forming cells.
By showing significant suppression of erythroid colony forming cell growth, our data differ from published findings on mixed cancers6 and rheumatoid arthritis,12 30 in which erythroid colony forming cell numbers in normal and diseased donors were similar.
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Masters, Baines, Bailey-Wood, Gorvett, Littlewood, Bentley, Parry-Jones, Jacobs There are some methodological differences between these earlier studies and the work we report here, and these could be critical to the results.
Although none of the irregularities in blood and marrow cell populations apparently correlates with haemoglobin concentration or erythroid colony forming cell numbers in patients with bronchial cancer, a qualitative rather than a quantitative change in neutrophils, monocytes, or lymphocytes may be responsible for impaired erythropoiesis. 12 -14 Indeed, marrow adherent cells from anaemic patients with chronic disease have been shown to inhibit in vitro erythropoiesis.'3 31 Any inhibitory factor would have to act over a short range as we have been unable to corroborate a previous report'1 that inhibitors of erythropoiesis circulate in bronchial cancer sera. Only one of our bronchial cancer sera proved inhibitory when added to normal marrow cultures containing 25% AB serum; most "weakly supported" erythroid colony formation. Our observation that several bronchial cancer sera "strongly supported" erythroid colony forming cell proliferation is consistent with our earlier report9 that some patients with bronchial cancer do respond to their anaemia by increasing production of erythropoietin (and perhaps other positive regulators of erythropoiesis as well).
To summarise, considerable perturbations occur in mature haemopoietic populations and in the erythroid progenitor compartments in patients with bronchial cancer, although the associations between these phenomena are obscure and their role, if any, in the onset of anaemia remains undefined. Anaemia in bronchial cancer may result from the interplay of several of these population inbalances or, alternatively, the changes reported here may be epiphenomena associated with a more fundamental haemopoietic defect.
